71904-200-01 |
71904-200 |
HUMAN PRESCRIPTION DRUG |
POMBILITI ATGA |
cipaglucosidase alfa-atga |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20231011 |
N/A |
BLA |
BLA761204 |
AMICUS THERAPEUTICS US, LLC |
CIPAGLUCOSIDASE ALFA |
105 mg/1 |
1 VIAL, GLASS in 1 CARTON (71904-200-01) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
71904-200-02 |
71904-200 |
HUMAN PRESCRIPTION DRUG |
POMBILITI ATGA |
cipaglucosidase alfa-atga |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20231011 |
N/A |
BLA |
BLA761204 |
AMICUS THERAPEUTICS US, LLC |
CIPAGLUCOSIDASE ALFA |
105 mg/1 |
10 VIAL, GLASS in 1 CARTON (71904-200-02) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
71904-200-03 |
71904-200 |
HUMAN PRESCRIPTION DRUG |
POMBILITI ATGA |
cipaglucosidase alfa-atga |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20231011 |
N/A |
BLA |
BLA761204 |
AMICUS THERAPEUTICS US, LLC |
CIPAGLUCOSIDASE ALFA |
105 mg/1 |
25 VIAL, GLASS in 1 CARTON (71904-200-03) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |